News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Fennec Pharmaceuticals Announces PEDMARK® (sodium thiosulfate injection) Receives Orphan Drug Exclusivity from U.S. FDA
Wednesday, February 01, 2023Fennec Pharmaceuticals Inc a commercial stage specialty pharmaceutical company today announced that the US Food and Drug Administration FDA has granted Orphan Drug Exclusivity to PEDMARK sodium thiosulfate injection which is indicated to reduce the r...
West Announces Three New Product Innovations at Pharmapack Europe
Wednesday, February 01, 2023West Pharmaceutical Services Inc a global leader in innovative solutions for injectable drug administration today announced participation at Pharmapack Europe in Paris France to showcase its leadership and expertise on industry challenges and trends...
Charles River Laboratories Acquires SAMDI Tech
Tuesday, January 31, 2023Charles River Laboratories International Inc announced today that it has acquired SAMDI Tech Inc a leading provider of highquality labelfree highthroughput screening HTS solutions for drug discovery research The acquisition marks the culmination of a...
Irwin Naturals Signs Letter of Intent to Acquire Braxia Scientific
Tuesday, January 31, 2023Irwin Naturals Inc is pleased to announce it has entered into a nonbinding amended and restated Letter of Intent LOI for a business combination with Braxia Scientific Corp a medical research company providing psychiatric innovative ketamine and psilo...
Elixirgen Therapeutics Enters Memorandum of Understanding with Hitachi Global Life Solutions for the Development of Micro GMP Suites for Cell Therapy Administration
Friday, January 27, 2023Elixirgen Therapeutics Inc a clinicalstage biotechnology company focused on the discovery development and commercialization of therapies using its controllable selfreplicating RNA csrRNA platform today announced that it has entered a memorandum of un...
Nogra Pharma announces out-licensing agreement with Torii Pharmaceutical for Japan for New Chemical Entity topical acne treatment
Friday, January 27, 2023Nogra Pharma a clinical stage biotechnology company developing innovative therapeutics for immuneinflammatorymediated diseases
Alvotech and Bioventure Announce Approval of AVT02 (adalimumab) as Simlandi in Saudi Arabia
Wednesday, January 25, 2023Alvotech and Bioventure a wholly owned subsidiary of GlobalOne Healthcare Holding LLC GHH the healthcare division of Yas Holding LLC today announced that the Saudi Food Drug Authority SFDA has approved the manufacturing and distribution of AVT a bio...
Stevanato Group Collaborates with Transcoject to Provide Pre-Fillable Syringe Polymer Options for Pharma
Wednesday, January 25, 2023Stevanato Group SpA a leading global provider of drug containment and delivery solutions to the pharmaceutical biotechnology and life sciences industries announced its latest collaboration with Transcoject GmbH a medical device and pharma packaging s...
IntelGenx and Arwan Enter into a Supply Agreement for RIZAPORT® in MENA Countries
Tuesday, January 24, 2023IntelGenx Corp a leader in pharmaceutical films announced today that it has entered into an exclusive supply agreement for RIZAPORT the Product with ARWAN Pharmaceuticals Industries Lebanon sal ARWAN in various countries in the Middle East and North...
CytoReason to License Its IBD Disease Model to Sanofi in Expanded Multiyear, Multimillion Dollar Deal
Tuesday, January 24, 2023CytoReason a leader and pioneer in computational disease modeling today announced an expansion of its collaboration with Sanofi The multiyear collaboration will further fuel Sanofis target discovery efforts via CytoReasons AI platform in the field of...
